Stick and Glue! Researchers at IOCB Prague introduce a new biomolecule-labeling method for more precise observation of cellular processes
Peer-Reviewed Publication
Updates every hour. Last Updated: 1-Jan-2026 17:12 ET (1-Jan-2026 22:12 GMT/UTC)
A team of researchers at IOCB Prague headed by Dr. Tomáš Slanina has developed a new method for labeling molecules with fluorescent dyes that surpasses existing approaches in both precision and stability. The new fluorescent label remains covalently bonded to its target molecule and does not fall apart even under demanding conditions inside living cells. This allows scientists to track labeled molecules over long periods with high reliability – an advantage for research in biology, chemistry, and medicine. The study was published in Angewandte Chemie International Edition.
Combining genetic risk with cardiovascular disease risk factors — such as high LDL cholesterol, obesity, and hypertension — may predict who is more likely to develop dementia, according to a new study led by UC San Francisco.
Current antibody-based treatments for Alzheimer’s disease remain costly and carry significant side effects, highlighting the need for safer alternatives. In a new study, researchers from Kindai University report that oral administration of arginine suppresses amyloid-β aggregation and related neurotoxicity in fruit fly and mouse models of Alzheimer’s disease. Their findings demonstrate arginine’s potential as a safe, inexpensive, and readily available repositioned drug candidate for preventing or mitigating Alzheimer’s pathology.
The liver plays a central role in storing and supplying energy to the body. In type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, commonly referred to as fatty liver disease), mitochondria—the cell’s power plants—cannot switch efficiently between fuel sources. Scientists at the German Diabetes Center (DDZ), Heinrich-Heine-University Düsseldorf (HHU), the University Hospital Düsseldorf (UKD) and the German Center for Diabetes Research (DZD) measured, for the first time, how well mitochondria in heart, muscle, liver, and kidney can use the breakdown products of fats – ketone bodies – to produce energy. Ketone body levels can be increased through fasting, exercise, or low-carbohydrate diets. The study shows that energy generation via ketone body metabolism is reduced in insulin resistance such as in type 2 diabetes and MASLD, highlighting a potential new target for improving energy metabolism in diabetes.